Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Non peptide compound")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 2981

  • Page / 120
Export

Selection :

  • and

Structure elucidation and conformational study of V8 : A novel synthetic non peptide AT1 antagonistZOUMPOULAKIS, Panagiotis; POLITI, Aggeliki; GRDADOLNIK, Simona Golic et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 40, Num 5, pp 1097-1104, issn 0731-7085, 8 p.Article

Nonpeptide antagonists for kinin receptorsALTAMURA, M; MEINI, S; QUARTARA, L et al.Regulatory peptides. 1999, Vol 80, Num 1-2, pp 13-26, issn 0167-0115Article

Effect of continuous venovenous hemodiafiltration on darunavir and raltegravir exposure after administration via a gastroduodenal tubeTAEGTMEYER, Anne B; MÜLLER, Veronique; KOVARI, Helen et al.AIDS (London). 2011, Vol 25, Num 10, pp 1339-1341, issn 0269-9370, 3 p.Article

Progress toward re-engineering non-ribosomal peptide synthetase proteins : A potential new source of pharmacological agentsSTEVENS, Brian W; JOSKA, Tammy M; ANDERSON, Amy C et al.Drug development research. 2005, Vol 66, Num 1, pp 9-18, issn 0272-4391, 10 p.Article

Tachykinin NK1 receptor antagonistsPATACCHINI, R; MAGGI, C. A.Handbook of experimental pharmacology. 2004, Vol 164, pp 173-218, issn 0171-2004, 46 p.Article

Capillary electrophoresis-based sirtuin assay using non-peptide substratesYI FAN; HENSE, Martina; LUDEWIG, Ronny et al.Journal of pharmaceutical and biomedical analysis. 2011, Vol 54, Num 4, pp 772-778, issn 0731-7085, 7 p.Article

Metabolism and Disposition of Eltrombopag, an Oral, Nonpeptide Thrombopoietin Receptor Agonist, in Healthy Human SubjectsYANLI DENG; MADATIAN, Armina; GORYCKI, Peter D et al.Drug metabolism and disposition. 2011, Vol 39, Num 9, pp 1734-1746, issn 0090-9556, 13 p.Article

Darunavir : pharmacokinetics and drug interactionsBACK, David; SEKAR, Vanitha; HOETELMANS, Richard M. W et al.Antiviral therapy (London). 2008, Vol 13, Num 1, pp 1-13, issn 1359-6535, 13 p.Article

Characterisation of the binding of [3H]-SB-674042, a novel nonpeptide antagonist, to the human orexin-1 receptorLANGMEAD, Christopher J; JERMAN, Jeffrey C; BROUGH, Stephen J et al.British journal of pharmacology. 2004, Vol 141, Num 2, pp 340-346, issn 0007-1188, 7 p.Article

Evidence that corticotropin-releasing factor receptor type 1 couples to Gs- and Gi-proteins through different conformations of its J-domainBERGER, H; HEINRICH, N; WIETFELD, D et al.British journal of pharmacology. 2006, Vol 149, Num 7, pp 942-947, issn 0007-1188, 6 p.Article

Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonistRANSOM, Richard W; HARRELL, Charles M; SU, Dai-Shi et al.European journal of pharmacology. 2004, Vol 499, Num 1-2, pp 77-84, issn 0014-2999, 8 p.Article

Synthesis and evaluation of nonpeptide substituted spirobenzazepines as potent vasopressin antagonistsMIN AMY XIANG; CHEN, Robert H; DEMAREST, Keith T et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 12, pp 3143-3146, issn 0960-894X, 4 p.Article

Characterization of the anti-platelet actions of FK419, a novel non-peptide antagonist of platelet GPIIb/IIIaMIHARA, Kayoko; AOKI, Toshiaki; MUTOH, Seitaro et al.Drug development research. 2004, Vol 61, Num 4, pp 233-241, issn 0272-4391, 9 p.Article

Novel scaffolds for non-peptide mimetics of δ opioid receptor agonists based on peptide leadsQIAN, X; LIAO, S; STROPOVA, D et al.Regulatory peptides. 1996, Vol 65, Num 1, pp 79-82, issn 0167-0115Article

Les propriétés pharmacocinétiques du darunavirTRIBUT, Olivier.La Lettre du pharmacologue. Supplément (Boulogne). 2008, Vol 22, Num 2, pp 8-10, issn 1245-4893, 3 p.Article

Peptide and nonpeptide lead discovery using robotically synthesized soluble librariesFAUCHERE, J. L; HENLIN, J. M; BOUTIN, J. A et al.Canadian journal of physiology and pharmacology. 1997, Vol 75, Num 6, pp 683-689, issn 0008-4212Conference Paper

Effect of the non-peptide blocker (±) CP 96,345 on the cellular mechanism involved in the response to NK1 receptor stimulation in human skin fibroblastsZICHE, M; PARENTI, A; AMERINI, S et al.Neuropeptides (Edinburgh). 1996, Vol 30, Num 4, pp 345-354, issn 0143-4179Article

Tachykinin NK3 receptor antagonistsMAZZONE, S. B; CANNING, B. J.Handbook of experimental pharmacology. 2004, Vol 164, pp 245-271, issn 0171-2004, 27 p.Article

Discovery of a new class of antihypertensive agents, nonpeptide angiotensin II receptor antagonists : Candesartan cilexetilNAKA, Takehiko.Nippon Nōgei Kagakukaishi. 2000, Vol 74, Num 7, pp 787-790, issn 0002-1407Article

Bioavailability and bioequivalence of a darunavir 800-mg tablet formulation compared with the 400-mg tablet formulationKAKUDA, Thomas N; LEOPOLD, Lorant; TIMMERS, Maarten et al.International journal of clinical pharmacology and therapeutics. 2014, Vol 52, Num 9, pp 805-816, issn 0946-1965, 12 p.Article

Virological analysis of once-daily and twice-daily darunavir/ritonavir in the ODIN trial of treatment-experienced patientsLATHOUWERS, Erkki; DE LA ROSA, Guy; VAN DE CASTEELE, Tom et al.Antiviral therapy (London). 2013, Vol 18, Num 3, pp 289-300, issn 1359-6535, 12 p.Article

Lead diversification. Application to existing drug molecules: Mifepristone 1 and antalarmin 8ABID MASOOD, M; FARRANT, Elizabeth; MORAO, Inaki et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 1, pp 723-728, issn 0960-894X, 6 p.Article

Neither ritonavir nor darunavir affect cell surface expression of tetherin or Vpu-mediated tetherin down-modulationKUHL, Björn D; SLOAN, Richard D; DONAHUE, Daniel A et al.AIDS (London). 2010, Vol 24, Num 12, pp 1970-1972, issn 0269-9370, 3 p.Article

Effect of Tipranavir-Ritonavir on Pharmacokinetics of RaltegravirHANLEY, William D; WENNING, Larissa A; MOREAU, Allison et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 7, pp 2752-2755, issn 0066-4804, 4 p.Article

Different evidence of key amprenavir resistance mutations on the efficacy of darunavirDI BIAGIO, Antonio; ROSSO, Raffaella; BRUZZON, Bianca et al.AIDS (London). 2008, Vol 22, Num 3, pp 437-438, issn 0269-9370, 2 p.Article

  • Page / 120